Daniel Siegel, MD, MS, FAAD, FACMS, CPCD

Daniel M. Siegel, MD, Clinical Professor of at SUNY Downstate Health Sciences University, New York, former President and honorary member of the American Academy of Dermatology (AAD).

Dr. Siegel a graduate of Albany Medical College in New York, completed his residency in dermatology at Parkland Memorial Hospital in Dallas, Texas, followed by a fellowship in Mohs Micrographic Surgery and Dermatologic Surgery at Baylor College of Medicine in Houston, Texas. Dr. Siegel also earned a Master of Science degree in Management and Policy from the W. Averell Harriman School for Management and Policy, SUNY  Stony Brook, and holds an Advanced Certificate in Labor/Management.

A diplomate of the American Board of Dermatology and a fellow of the AAD, the American College of Mohs Surgery (ACMS) and the American Society for Mohs Surgery,  he has served on the board of directors for many of these societies, including the American College of Mohs Surgery, the AAD, the American Dermatological Association and the Women’s Dermatologic Society. Dr. Siegel was a founding board member of debRA International and a former trustee of Dystrophic Epidermolysis Bullosa Research Association of America, Inc. (DebRA,) He was also a trustee of the Noah Worcester Dermatological Society and has run the Scientific Program Committee for five of its annual meetings and its President 2019-2021. He is one of the 20 esteemed active members of the New York Dermatological Society. 

Active internationally, he served as board member (2015-2023) of the International League of Dermatological Societies, a “society of societies” that coordinates a quadrennial world congress and supports the Regional Dermatology Training Center in Moshi, Tanzania that has trained hundreds of physicians in sub-Saharan Africa.  In April 2017 he was elected to the board of directors of the International Society of Dermatology where he now serves as a vice president.  He was asked to join the board of IDEOM in 2020.

Dr. Siegel has published over 200 articles and book chapters in major medical journals and textbooks. He is a reviewer, editor, or advisor for many dermatology journals. His expertise extends outside of “routine” dermatology including IT and botany. He also served from 2003 to 2010 as the AAD representative to American Medical  Association Specialty Society RVS Update Committee (RUC) and currently serves as the AAD advisor to the RUC.

Dr. Siegel received the 2023 American Academy of Dermatology Gold Medal, the AAD’s highest award presented on a very selective basis to acknowledge outstanding and exceptional service in the field of dermatology, the  2013 American Skin Association Public Policy & Medical Education Award and the 2012 Clinical Educator Award from the 2012 Winter Clinical Dermatology Conference. Among Dr. Siegel’s many other awards are multiple American Academy of Dermatology Presidential Citations and he was the 2009 recipient of the President’s Volunteer Service Award. In recognition of his years of service to the profession, he was awarded honorary membership in the American Academy of Dermatology in 2015.

Education

• Undergraduate: Rensselaer Polytechnic Institute, Troy, New York
• Medical School: Albany Medical College, Albany New York
• Internship: Categorical Diversified Internal Medicine Intern, Albany Medical Center Hospital, Albany, New York
• Residency: Dermatology Resident and Chief Resident, Parkland Memorial Hospital UT Southwestern, Dallas, Texas.
• Fellowship: Mohs Micrographic Surgery and Dermatologic Surgery, Baylor College of Medicine, Houston, Texas.

Research interests

• Skin Cancer and cutaneous surgery; Non-invasive imaging; computer applications in dermatology; botanical therapeutics, Coding, reimbursement and payment policy.

Conditions and Treatments

• Surgical therapy 

• Jaimes N, Scope A, Welzel J, Lee D, Wang K, Siegel D and Marghoob AA. "White Globules in Melanocytic Neoplasms: In-Vivo and Ex-Vivo Characteristics." Dermatol Surg 2012 38(1): 128.
• Hui AM, Jacobson M, Markowitz O, Brooks NA and Siegel DM. "Mohs Micrographic Surgery for the Treatment of Melanoma." Dermatologic Clinics, July 2012 30(3): 503-515.
• Jagdeo JR, Adams LE, Brody NI, Siegel DM. "Transcranial Red and Near Infrared Light Transmission in a Cadaveric Model." PLoS ONE (2012) 7(10): e47460. DOI 10.1371/journal.pone.0047460 PDF ».
• Serravallo M, Jagdeo J, Glick SA, Siegel DM and Brody NI. " Sirtuins in dermatology: applications for future research and therapeutics." 2013, Arch Dermatol Res, DOI 10.1007/s00403-013-1320-2
• Lev-Tov H, Brody N, Siegel D, Jagdeo J. Inhibition of fibroblast proliferation in vitro using low-level infrared light-emitting diodes. Dermatol Surg. 2013, Mar;39(3 Pt 1):422-5. doi: 10.1111/dsu.12087. Epub 2012 Dec 26.
• Kaur RR, Glick JB, Siegel D. Achieving hemostasis in dermatology - Part 1:Preoperative, intraoperative, and postoperative management. Indian Dermatol Online J [serial online] 2013 [cited 2013 Apr 17 ];4:71-81 Available here »
• Lev-Tov H, Mamalis A, Brody N, Siegel D, Jagdeo J. Inhibition of Fibroblast Proliferation In Vitro Using Red Light-Emitting Diodes. Dermatol Surg. 2013 Aug;39(8):1167-70. Dermatol Surg. 2013 Apr 16. doi: 10.1111/dsu.12212. [Epub ahead of print]
• Wang KX, Meekings A, FluhrJW, McKenzie G, Lee DA, Fisher J, Markowitz O and Siegel DM. Optical Coherence Tomography-Based Optimization of Mohs Micrographic Surgery of Basal Cell Carcinoma: A Pilot Study. Dermatol Surgery, April 2013(39):4, 627-633.
• Mamalis A, Fiadorchanka N, Adams L, Serravallo M, Heilman E, Siegel D, Brody N, Jagdeo J. An immunohistochemical panel to assess ultraviolet radiation- associated oxidative skin injury. J Drugs Dermatol. 2014 May 1;13(5):574-8. PubMed PMID: 24809881.
• Williams EL, Derek Ho MK, Halpern AC, Markowitz O and Siegel DM. Relationship Between Melanoma Detection Pattern and Tumor Thickness. Am J Prev Med. 2014 Jul 26. pii: S0749-3797(14)00237-2. doi: 10.1016/j.amepre.2014.05.019. [Epub ahead of print]